Summary
Lumentum Holdings Inc. reported a net loss of $39.3 million, or $0.57 per diluted share, for the third quarter of fiscal year 2023, a significant shift from the net income of $26.0 million, or $0.35 per diluted share, reported in the same quarter last year. This downturn was primarily driven by a substantial decrease in gross margin, which fell to 29.2% from 42.3% year-over-year. The company cited a less profitable product mix, particularly in the OpComms segment, alongside increased inventory charges, amortization of acquired intangibles, and higher incremental supply costs as key factors impacting profitability. Despite the quarterly loss, Lumentum's nine-month performance showed a year-over-year revenue increase of 8.2% to $1,396.2 million, largely fueled by the NeoPhotonics acquisition. However, the gross margin for the nine-month period also contracted significantly, decreasing to 34.3% from 47.0%. Management highlighted ongoing supply chain constraints and customer inventory management as contributing factors to current market conditions and ordering patterns. The company's balance sheet reflects continued investment in acquisitions, with goodwill increasing substantially.
Key Highlights
- 1For the third quarter of fiscal year 2023, Lumentum reported a net loss of $39.3 million, a reversal from a net income of $26.0 million in the prior year's quarter.
- 2Gross margin significantly declined to 29.2% in Q3 FY23 from 42.3% in Q3 FY22, attributed to product mix, inventory charges, and increased costs.
- 3Nine-month revenue increased by 8.2% to $1,396.2 million, primarily due to the NeoPhotonics acquisition, although gross margin for this period also decreased.
- 4Operating expenses rose, with R&D increasing by 50.6% and SG&A by 19.7% year-over-year, largely due to integration costs and headcount from recent acquisitions.
- 5The company's cash and cash equivalents decreased by $741.0 million from July 2, 2022, to April 1, 2023, reflecting cash used in investing and financing activities.
- 6Goodwill increased substantially due to acquisitions, with $316.4 million from NeoPhotonics and $10.9 million from IPG product lines recognized during the nine months.
- 7The company continues to repurchase its stock, with an increased authorization of $1.2 billion through May 2025, though share repurchases in the current quarter were minimal.